Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FVHD0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,645
Award facts
- Contract value 100% obligated
- $6,645.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,645.19 to AmerisourceBergen Drug Corp for GEMTESA 75 mg tablets (90-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price contract, classified as a non-set-aside competitive award, represents a direct procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that extends through December 2026. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order exemplifies the routine pharmaceutical procurement operations conducted through AmerisourceBergen's prime vendor relationship with DLA, whereby the contractor supplies medications, medical devices, and healthcare commodities to support military healthcare programs and Defense Health Agency operations worldwide. GEMTESA (mirabegron), a medication used to treat overactive bladder, falls within the diverse therapeutic portfolio that AmerisourceBergen provides under its comprehensive IDC arrangement. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains extensive capabilities to fulfill such delivery orders competitively and efficiently across the full spectrum of military healthcare supply requirements.
Quick answers
Who was awarded contract SPE2DB25FVHD0?
SPE2DB25FVHD0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FVHD0 worth?
The government has obligated $6,645 on SPE2DB25FVHD0.
Is contract SPE2DB25FVHD0 an order under another contract?
Yes. SPE2DB25FVHD0 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVHD0 competed?
The extent of competition for SPE2DB25FVHD0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award